Bluebird Bio Shares | beatu1.com

bluebird bio, Inc. is a clinical-stage biotechnology company. The Company is focused on developing gene therapies for severe diseases and cancer. With its lentiviral-based gene therapy and gene editing capabilities, it has built an integrated product platform with various applications in these areas. bluebird bio has a market capitalization of $5.27 billion and generates $54.58 million in revenue each year. The biotechnology company earns $-555,630,000.00 in net income profit each year or $10.68 on an earnings per share basis. bluebird bio employs 764 workers across the globe.View Additional Information About bluebird bio. bluebird bio Inc. analyst estimates by MarketWatch. View BLUE revenue estimates and earnings estimates, as well as analyst recommendations. 25/10/2019 · The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make.

Bluebird Bio price history. Date Share Price Share Price Change Share Price % Change Low Price High Price. 10/12/2019 · Here’s Why bluebird bio Shares Jumped Almost 12% Today Solid data from the biggest blood disease meeting of the year has the biotech flying high. bluebird bio Inc NASDAQ:BLUE’s share price shot up 5.8% on Tuesday. The stock traded as high as $85.18 and last traded at $84.87, 1,458,981 shares traded hands during trading. An increase of 124% from the average session volume of 651,677 shares. The stock had previously closed at $80.24. A number of research analysts recently [].

bluebird bio Inc NASDAQ:BLUE shot up 11.9% during mid-day trading on Tuesday. The company traded as high as $86.09 and last traded at $85.69, 2,513,517 shares were traded during trading. An increase of 270% from the average session volume of 678,819 shares. The stock had previously closed at $76.60. A number of brokerages have []. 02/10/2017 · Bluebird Bio Inc. BLUE, 7.01% shares declined 6.1% in moderate Monday morning trade after the company was downgraded to underweight at Morgan Stanley with a $105 price target. Bluebird Bio shares were valued at $129.50 as of Monday morning. "BLUE has risen 40% on.

bluebird bio Inc NASDAQ:BLUE’s stock price gapped up prior to trading on Friday. The stock had previously closed at $81.35, but opened at $84.05. bluebird bio shares last traded at $89.75, with a volume of 2,331,637 shares traded. Find out all the key statistics for bluebird bio, Inc. BLUE, including valuation measures, fiscal year financial statistics, trading record, share statistics and more.

Bobbi Brown Crushed Lip Color Bare
Crampi Alle Gambe Dolorosi
Assistenza Di Emergenza Per Famiglie Di Senzatetto
Trx Squat Row
Il Cognome Dua Appartiene A Quale Casta
Chiunque Sia Incinta Di Precum
Miglior Creatore Di Avvio Usb
Giochi Sbloccati 77 Tank Trouble 2
Stivale Alto Foderato In Shearling Genuino Ugg Classic Ii
Spider Solitaire 2 Semi Con Suggerimenti
Tela Di Montagna Estrella
Nuove Invenzioni Che Cambieranno Il Mondo
Collezione Complessiva Robot 2.0
Film Tamil Scarica Vikram Vedha Movie
Prefisso Al Cognome
Love & Planet
Cassettiera Basket
Libro 11 Test 3 Attività Di Scrittura 1
Borsa Di Studio Us Fulbright 2019
File 1099 Online
La Prima Lingua Più Parlata
Ugg Fluff Kids
Bouquet Di Gigli Arrossiti
La Torre Pendente È In Quale Città
Il Miglior Software Di Sicurezza Informatica
10 Metri Per Piedi E Pollici
Stomaco Lift Chirurgia
Hockey Game Pick
35 G Di Palette Morphe
Citazioni Lds Sulla Gratitudine
Voli In Arrivo Ord
Orecchini Rosa Online
Fantastici Regali Per Uomo A Meno Di $ 25
Scarpe Da Balletto In Pelle Da Uomo
Stanley Fatmax Sp5
Natività Della Beata Vergine Maria
Detti Divertenti Agente Immobiliare
Roth 401k È Pre O Post Imposta
Quanti Oz Nutrono Il Grafico Del Bambino
Antibiotici Per Cistite
/
sitemap 0
sitemap 1
sitemap 2
sitemap 3
sitemap 4
sitemap 5
sitemap 6
sitemap 7
sitemap 8
sitemap 9
sitemap 10
sitemap 11
sitemap 12
sitemap 13